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The chief goal of cancer therapeutics has been the discovery of exploitable differences 
between cancer and normal cells, to allow for selective toxicity.  Sixty years of intensive 
research have largely been an exercise in futility. However, cancer cannot exist without 
a blood supply and there is ample evidence of very important differences between 
embryonic and tumor vasculature, on one hand, and the vasculature of mature, adult 
tissues, on the other hand1. Better tools are needed for studying, understanding, and 
exploiting these differences.
Calcium influx and intracellular calcium release are felt to modulate endothelial cell 
proliferation, but sustained calcium influx has also been shown to be associated with 
endothelial cell death2-5.  We previously described a novel method for detecting 
endothelial cell death in primary cell cultures prepared from fresh biopsy specimens of 
human tumors and from peripheral blood6. We report here that the distinctive cytological 
staining of dead endothelial cells observed in our method is the result of calcium 
accumulation and that staining for calcium (in the present case, with Alizarin red S) 
affords a sensitive method for detecting endothelial cell death in vitro.
Figure 1 shows the distinctive cytologic appearance of of fresh human tumors which 
were cultured without and with bevacizumab (2.5 mg/ml, which is a concentration 
sufficient to remove all detectable VEGF from cell culture supernatants6). Dead 
endothelial cells have a distinctive hyperchromatic, blue-black appearance following the 
addition of the dye Fast Green to the culture medium, followed by Cytocentrifugation 
onto microscope slides, followed by counterstaining with Hematoxylin-eosin.  
Hematoxylin is known to form a blue-black “lake” effect, in the presence of calcium7.  
This staining, at least in dead endothelial cells, is markedly accentuated by pre-
incubation with Fast Green, in our experience.  
In the earlier publication6, we speculated that the distinctive dead endothelial cell 
staining was owing to the dye exclusion principle, wherein living cells, with intact cell 
membranes, would exclude Fast Green, but that Fast Green penetrated dead cells, with 
incompetent cell membranes, thereby staining the dead endothelial cells. However, this 
explanation did not entirely explain the fact that the dead endothelial cells stain much 
more hyperchromatically and appeared to be refractile, in some cases, and even to 
have a crystalline appearance, in other cases (Figure 2).  We suspected that the 
distinctive staining of the dead endothelial cells might be owing to a calcium effect.
We then cultured fresh human tumors and normal peripheral blood (contains circulating 
endothelial cells) in the presence and absence of bevacizumab and prepared Cytospin 
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slides with Fast Green/Hematoxylin-eosin, Fast Green/Wright-Giemsa, Fast Green/
Alizarin red S (reasonably specific for calcium http://www.ihcworld.com/_protocols/
special_stains/alizarin_red_s.htm), Alizarin red S alone, and Alizarin red S, followed by 
Wright-Giemsa.
Figure 3 shows the dramatic difference between control and bevacizumab-exposed 
tumor cultures.  The distinction between Alizarin red S and background material was 
greatest (from the standpoint of image analysis) when cells were first sedimented onto 
microscope slides, air dried, and stained only with Alizarin red S, and then 
photographed, without coverslips, for image analysis (Figure 3C, Table 1).  These slides 
could then be coverslipped, with or without subsequent counterstaining with Wright-
Giemsa (counterstaining with Hematoxylin-eosin or Hematoxylin alone had the effect of 
bleaching out the Alizarin red S stain).
There are currently no convenient, sensitive, specific methods for testing the effect of 
putative anti-angiogenic agents on human tumor-associated human endothelial cells, 
either generally or on an individual patient basis.  Our present method affords such a 
method.  For the purpose of high-throughput studies, one could test circulating 
peripheral blood endothelial cells from cancer patients (in whom circulating endothelial 
cells are often increased8-11 and which originate, presumably, from tumor-associated 
capillaries) compared to endothelial cells from peripheral blood from normal volunteers, 
using simple, public domain image analysis software (http://rsbweb.nih.gov/ij/ ), and  the 
Octospot cytocentrifuge system (http://www.testlaboratories.co.uk/products.asp ). 
Furthermore, the present studies suggest that bevacizumab-induced endothelial cell 
death (almost certainly resulting from VEGF depletion of the cell culture medium6) 
occurs via a calcium-accumulation mechanism.  In addition to bevacizumab, other 
agents, including protein kinase inhibitors, ethanol, and/or dimethylsulfoxide also 
produce endothelial cell death in some specimens of human neoplasms through a 
mechanism which also produces intense calcium staining (most likely signifying calcium 
accumulation)6,12,13, with the ethanol/calcium-influx/endothelial death finding supported 
independently by other evidence, in a different experimental system 4.  Additional 
support for our findings is the report that VEGF can function as a specific calcium 
channel blocker14. Removal of VEGF (e.g. with bevacizumab) could then lead to 
calcium entry and endothelial cell death.
In summary: 1.)The mechanism of endothelial cell death in human tumorsexposed to 
bevacizumab and some other agentsappears to involveabundant accumulations of 
calcium. These accumulations occuratlevels vastly exceedingthoseobserved in other 
types of normal and neoplastic cells, making calcium accumulation a sensitive and 
relatively specific marker for dead endothelial cells in primary human cell culture. 
Furthermore, perturbation of endothelial calcium influx affords a potential mechanism to 
augment the effect of agents such as bevacizumab.  2.) Calcium staining using our 
methodologies provides a convenient means for identifying and studying therapeutic 
agents targeting endothelial cells.
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Figure Legends:
Figure 1 Effect of bevacizumab (Avastin) on three dimensional primary cell culture of 
human solid tumors (post-culture stained with Fast Green/Hematoxylin&Eosin). Shown 
are assays performed on 8 different solid tumor specimens. Fresh solid tumor biopsies 
were minced and enzyme-digested. Three dimensional tumor clusters were enriched 
and cultured for 96 hours in anchorage-independent conditions in the absence (not 
shown) and presence of bevacizumab, 2.5 mg/ml, (which removes all detectable VEGF 
from the culture medium5), and stained with Fast Green/Hematoxylin&Eosin (methods 
described and referenced previously5). Living cells stain pink-red with H&E. Dead tumor 
and normal, non-endothelial cells stain blue green. Dead endothelial cells stain blue-
black and produce surrounding blue-black “lakes.” These cells correspond in size and 
location to CD31(endothelial antigen)-stained cells5. Control cultures virtually never 
exhibit these blue-black features, as documented in the previous publication5.
Figure 2 Effect of bevacizumab (Avastin) and other agents on primary cell culture of 
human non-Hodgkins lymphoma (panel A), myeloma (panel B), and normal peripheral 
blood cells (panel C). Lymphatic cells and associated endothelial cells were isolated 
from a lymph node biopsy (panel A), a bone marrow aspirate (panel B), and a peripheral 
blood specimen (panel C).  Cells were cultured for 96 hours in anchorage-independent 
conditions in the presence and absence of test articles, including bevacizumab 
(Avastin), bortezomib, epirubicin, fludarabine, and 0.5% DMSO + 0.5% ethanol. 
Following culture, cells were stained with Fast Green/Wright-Giemsa, according to 
previously-described methods5, or were stained with Alizarin red S (http://
www.urmc.rochester.edu/path/zqu/StainsManual/index.html?DAHLSMETHODFORCALCIUM ). 
Bevacizumab, bortezomib, and DMSO/ethanol produced blue-black stained,often highly 
refractile features and surrounding blue-black “lakes” which are thought to represent 
dead endothelial cells. Traditional cytotoxic agents (e.g. epirubicin, fludarabine) kill 
neoplastic cells, generally without producing the blue-black refractile features and lakes. 
Staining with Alizarin red S, followed by counterstaining with Wright-Giemsa, reveals 
that the blue-black, refractile features contain heavily concentrated calcium.
Figure 3 Effect of bevacizumab (Avastin) on three dimensional primary cell culture of 
human bladder (transitional cell) cancer:  Panel A, stained with Fast Green/
Hematoxylin&Eosin; Panel B, stained with Alizarin red S; Panel C, stained with Alizarin 
red S and raw images subsequently processed with public domain ImageJ software 
(http://rsbweb.nih.gov/ij/ ). In panel C, shown on left side are raw photomicrographic 
images (40X original magnification) of cells which were cultured in the absence (control) 
or presence of bevacizumab (Avastin).  These cells were stained with Alizarin red S, 
alone. The middle images of panel C show ImageJ-processed images, which were 
threshold gated to display all of the cellular material on the slide.  The right sided 
images of panel C show ImageJ-processed images, which were threshold gated to 
display only the Alizarin red S stained features. Quantitative analysis of these slides was 
performed, using ImageJ software, with representative results shown in Table 1.
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FIGURES
Figure 1 Effect of bevacizumab (Avastin) on three dimensional primary cell culture of 
human solid tumors (post-culture stained with Fast Green/Hematoxylin&Eosin)
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Figure 2 Effect of bevacizumab (Avastin) and other agents on primary cell culture of 
human lymphoma (panel A), myeloma (panel B), and normal peripheral blood cells 
(panel C) (post-culture stained with Fast Green/Wright-Giemsa, and, in the case of the 
normal cells, also with Alizarin red S - panel C, bottom)
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Figure 3 Effect of bevacizumab (Avastin) on three dimensional primary cell culture of 
human bladder (transitional cell) cancer:  Panel A, stained with Fast Green/
Hematoxylin&Eosin; Panel B, stained with Alizarin red S; Panel C, stained with Alizarin 
red S and raw images subsequently processed with ImageJ software.
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TABLE
Table 1. ImageJ analysis of bladder (transitional cell) cancer depicted in Figure 3.
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40X field 
sampled
Count of individual 
alizarin-gated features 
divided by total pixels 
of cell-gated features 
(* 10E6)
Area (total pixels) of 
alizarin-gated features 
divided by total pixels 
of cell gated features 
(* 10E5)
Avastin #1 366 8629
Avastin #2 321 5353
Avastin #3 378 6663
Avastin #4 280 2859
Avastin #5 218 6262
Avastin #6 343 7292
Mean 
Avastin
(95% C.I.)
318 
(218-378)
6176 
(4120-8232)
Control # 1 59 591
Control # 2 89 644
Control # 3 37 291
Control # 4 48 280
Control # 5 70 575
Control # 6 133 899
Mean 
Control 
(95% C.I.)
73 
(36-109)
547 
(301-791)
2-sided P
Students T
<0.0001 <0.0001
